Cipla clarified that its supply partner Pharmathen received nine USFDA Form 483 observations during a November 2025 inspection of its Greece facility for Lanreotide Injection, and the company is ...
Friday afternoon, the company and its partner Genmab shared word that the phase 3 Epcore DLBCL-1 trial missed on its primary ...
Cipla on Wednesday confirmed through an exchange filing that the firm'sLanreotide partner in Greece, Pharmathen, received a Form 483 notice at its Radopi unit.
Just The News on MSN
Oversight Chair Comer questions how Somali couriers accumulated millions sent abroad
“What I would like to know is where did they get the cash,” says House Oversight Committee Chairman James Comer. “Some ...
Freedom of Information Act requests filed with the Food and Drug Administration by hedge funds last month revealed big financial players closely eyeing warning letters, enforcement documents, and ...
Johnson & Johnson (NYSE:JNJ) Q4 2025 Earnings Call Transcript January 21, 2026 Johnson & Johnson reports earnings inline with ...
8h
Dr Reddy
Get all latest & breaking news on Dr Reddy. Watch videos, top stories and articles on Dr Reddy at moneycontrol.com.
AbbVie today announced topline results from the Phase 3 EPCORE® DLBCL-1 trial evaluating epcoritamab, a T-cell engaging ...
Get all latest & breaking news on Business Standard. Watch videos, top stories and articles on Business Standard at ...
Alvotech has five approved drugs, including biosimilars of AbbVie's Humira, Johnson & Johnson's Stelara/Simponi, and Eylea. See why ALVO stock is a Strong Buy.
Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on ...
The Food and Drug Administration has closed investigations into four outbreaks and is continuing to search for the cause of another. For an ongoing outbreak of Salmonella infections traced to Live it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback